NB-33, a bioreversible opioid derivative of Nalbuphine, shows enhanced pharmacodynamics.
Eur J Pharm Sci. 2021 Apr 1;159:105734. doi: 10.1016/j.ejps.2021.105734. Epub 2021 Jan 27.
Eur J Pharm Sci. 2021.
PMID: 33515698